Acetylcarnitine turnover in rat skeletal muscle measured in vivo using localized 13C NMR at 14.1 T by Bastiaansen, Jessica et al.
Acetylcarnitine turnover in rat skeletal muscle measured in vivo using localized 13C NMR at 14.1 T 
Jessica A. M. Bastiaansen1, Joao M. N. Duarte1,2, Arnaud Comment3, and Rolf Gruetter1,4 
1Laboratory of Functional and Metabolic Imaging, EPFL, Lausanne, Switzerland, 2Department of Radiology, University of Lausanne, Lausanne, Switzerland, 3Institute 
of Physics of Biological Systems, EPFL, Lausanne, Switzerland, 4Department of Radiology, University of Lausanne and Geneva, Lausanne and Geneva, Switzerland 
 
Introduction: Acetate has been widely used as a metabolic probe for measuring TCA cycle kinetics in vivo in skeletal muscle [1,2,3]. 
In order to cross the mitochondrial membrane for subsequent utilization in the TCA cycle, acetate needs to be transformed into 
acetylcarnitine [4]. Because of the relatively small poolsizes of acetylcarnitine in skeletal muscle approximately one order of 
magnitude lower than glutamate [5,6] it has only been observed in skeletal muscle in vivo using hyperpolarized 13C MRS [7]. The aim 
of this study was to be able to detect the [2-13C]acetylcarnitine resonance in vivo after the infusion of [2-13C]acetate in rat skeletal 
muscle by conventional  13C MRS at 14.1T using  localized DEPT, in order to enable improved characterization and description of  the 
system of enzymatic reactions involved in acetate oxidation. 
 
Materials and methods: Male Sprague Dawley rats (n = 6; 200-250g), fasted overnight, were positioned laterally and their hind limbs 
fixed on a custom designed holder to prevent motion. A home built 1H/13C coil with the proton loops in quadrature mode was placed 
on top of the skeletal muscle for localized and unlocalized 1H and 13C NMR data acquisition. Proton linewidths were adjusted to 30 ± 
5 Hz in a 6x10x12 mm3 voxel. Animals were infused with a dose of 200 umol/kg/min [2-13C]acetate for up to 6 hours through the 
jugular vein. Arterial plasma samples were taken throughout the experiment to determine plasma acetate fractional enrichments (FE).  
13C NMR spectra (128 averages) were acquired using semi-adiabatic distortionless enhancement by polarization transfer (DEPT) 
combined with a 3D ISIS localization scheme and outer volume suppression [8]. 13C spectra were analyzed with jMRUI. At the end of 
the experiment, tissue was rapidly excised and frozen in liquid nitrogen for 13C isotopomer analysis of perchloric acid extracts. FE of 
C2 acetylCoA was determined as described in [9]. 
 
Results and discussion: The sensitivity increase due to the high field and the use of a localized DEPT sequence allowed for the first 
time the observation of acetylcarnitine (AlCar) in vivo at 21.5 ppm. Other metabolites such as glutamate (C2, C3 and C4), creatine 
(CH2 and CH3), taurine (C1 and C2) and citrate were also clearly observed (Fig 1 & 2). In all experiments the FE of C2 acetate in 
plasma reached ~70% - 80%. The FE of C2 in acetylCoA varied between 0.5 and 0.6. NMR of tissue extracts revealed the presence 
off all metabolites observed in vivo, plus, interestingly, the resonances of glutamine (C2, C3 and C4) which were of the same order of 
magnitude as the glutamate resonances (Fig. 3). The resonance assigned to AlCar C2, also observed in unlocalized spectra with lipid 
baseline subtraction, could not be from lactate C3 since both were observed in tissue extracts at respectively 21.5 ppm and 21.0 ppm. 
Additionally, spectra were cross referenced with observed lactate resonances in brain studies in vivo from our institute and do not 
match with the AlCar C2 resonance.  
 
Conclusion: This study demonstrates for the first time, to our knowledge, the detection in vivo of acetylcarnitine using localized 13C 
NMR spectroscopy at high field. This allows for a more detailed characterization of acetate oxidation in skeletal muscle in vivo and in 
studies of metabolic disorders such as diabetes where carnitine deficiency occurs.  
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 Fig. 1: In vivo 13C localized spectra during [2-13C]acetate
infusion in rat skeletal muscle. Time resolution shown here
is 20 min. Sum of the last 2 acquisitions is shown on top. A
small residual lipid resonance is observed at ~ 30 ppm.  
 Fig. 2: Integrated spectral time course with a
20 min time resolution showing the 13C 
enrichment in C2, C3 and C4 of glutamate 
and C2 of AlCar.  
Fig. 3: Spectrum of a tissue extract showing
the glutamine, glutamate lactate and 
acetylcarnitine resonances. 
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